RecruitingNot ApplicableNCT07426731

Comparison of Sacral ESP Block and Dorsal Penile Nerve Block in Pediatric Hypospadias Surgery

Comparison of the Effects of Sacral Erector Spinae Plane Block and Dorsal Penile Nerve Block on Postoperative Pain Management in Pediatric Patients Undergoing Hypospadias Surgery

Sponsor

Medipol University

Enrollment

70 participants

Start Date

Feb 13, 2026

Study Type

INTERVENTIONAL

Conditions

Postoperative Pain Hypospadias

Summary

This randomized controlled trial aims to compare the postoperative analgesic efficacy of ultrasound-guided Sacral Erector Spinae Plane (ESP) block versus Dorsal Penile Nerve Block (DPNB) in pediatric patients aged 1-7 years undergoing hypospadias surgery. The primary outcome is the pain score assessed by the FLACC scale at the 12th postoperative hour

Eligibility

Sex: MALEMin Age: 1 YearMax Age: 7 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Dorsal Penile Nerve Block Group and a procedure called Sacral ESP Block Group for people with hypospadias and postoperative pain. The study is currently recruiting participants at 1 location. People eligible for this study include men aged 1 Year to 7 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURESacral ESP Block Group

Patients will be placed in the lateral decubitus position. Under ultrasound guidance, the plane between the multifidus muscle and the sacral lamina (erector spinae plane) will be identified at the sacral level. A total of 0.4 mL/kg of 0.25% Bupivacaine will be injected bilaterally

PROCEDUREDorsal Penile Nerve Block Group

Patients will be in the supine position. Under ultrasound guidance, the needle will be advanced under Buck's fascia at the penile base (pubic symphysis level). A total of 0.4 mL/kg of 0.25% Bupivacaine will be injected bilaterally